Barbara Cavalieri

Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: Prevention of reperfusion injury

Riccardo Bertini, Marcello Allegretti, Cinzia Bizzarri et al. · Proceedings of the National Academy of Sciences · 2004 · 339 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

Inhibition of interleukin-8 (CXCL8/IL-8) responses by repertaxin, a new inhibitor of the chemokine receptors CXCR1 and CXCR2

Federica Casilli, Andrea Bianchini, Isabelle Gloaguen et al. · Biochemical Pharmacology · 2004 · 109 citations

Life Sciences, Immunology, Pharmacology +14

The Interleukin-8 (IL-8/CXCL8) Receptor Inhibitor Reparixin Improves Neurological Deficits and Reduces Long-term Inflammation in Permanent and Transient Cerebral Ischemia in Rats

Pia Villa, Sara Triulzi, Barbara Cavalieri et al. · Molecular Medicine · 2007 · 89 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Receptor binding mode and pharmacological characterization of a potent and selective dual CXCR1/CXCR2 non‐competitive allosteric inhibitor

Riccardo Bertini, AR Beccari, Barbara Cavalieri et al. · British Journal of Pharmacology · 2011 · 74 citations · Full text

Medicine, Medicinal Chemistry, Pharmacokinetics +17

Reparixin, an Inhibitor of CXCR2 Function, Attenuates Inflammatory Responses and Promotes Recovery of Function after Traumatic Lesion to the Spinal Cord

Alfredo Gorio, Laura Madaschi, Giorgia Zadra et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 59 citations

Life Sciences, Neurobiology, Neuroscience +17